Saigon Biopharma

Saigon Biopharma is a commercial-stage pharmaceutical and biotechnology company headquartered in Ho Chi Minh City, Vietnam, with operations in the United States. The company specializes in the research and development of therapies derived from natural herbal origins integrated with modern medicinal chemistry. Its primary focus is on treating chronic diseases, including viral infections like HBV, HCV, and HIV, as well as liver conditions such as cirrhosis and hepatocellular carcinoma. Saigon Biopharma has several products registered for clinical trials on ClinicalTrials.gov and markets a range of drugs and dietary supplements globally. The company is also actively involved in developing treatments to neutralize spike glycoproteins in COVID-19 patients and addressing reproductive health issues like azoospermia.